Exposure to fine particulate matter can reduce IVF birth rate success, study reveals

FHS
July 8, 2024
4:38 pm

A pioneering study, presented today at the ESHRE 40th Annual Meeting in Amsterdam, has revealed that exposure to fine particulate matter (PM) prior to the retrieval of oocytes (eggs) during in vitro fertilization (IVF) can reduce the odds of achieving a live birth by almost 40%.

Risk Adjusted Net Present Value: What is the current valuation of Aligos Therapeutics’s ALG-009

The revenue for ALG-009 is expected to reach an annual total of $6 mn by 2037 globally based off GlobalData’s Expiry Model. The drug’s revenue

November 4, 2023

FDA’s warning to J&J’s Abiomed signals a crackdown on digital health tools

The Food and Drug Administration is following through on its promise to regulate more health software tools, starting with a public reprimand of Johnson &

October 16, 2023

BeiGene secures accelerated FDA approval for follicular lymphoma treatment – Pharmaceutical Technology

Share this article Follicular lymphoma is the second most common type of non-Hodgkin lymphoma, with approximately 15,000 cases in the US each year. Image credit:

March 8, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.